In Brief
Gantz and Bean show the endocannabinoid 2-AG excites isolated midbrain dopamine neurons through inhibition of A-type potassium current (I A ). 2-AG inhibits I A through membrane lipid interactions, independent of cannabinoid receptors, revealing a new action of endocannabinoids in regulating neuronal excitability.
INTRODUCTION
Lipid molecules in the membrane bilayer regulate ion channel function. Nonetheless, lipid signaling pathways controlling neuronal excitability are complex and still poorly understood (Hilgemann, 2003; Piomelli and Sasso, 2014) . In the mammalian brain, one of the most prominent lipid signaling pathways is that involving the endocannabinoids, anandamide and 2-arachidonoylglycerol (2-AG). Throughout the nervous system, endocannabinoids are generated from arachidonic acid-containing membrane phospholipids and released to modulate activity of neurons and circuits (Alger and Kim, 2011; Kano, 2014; Lu and Mackie, 2016 ).
Anandamide and 2-AG are synthesized in response to activation of G q/11 -protein-coupled receptors or increases in postsynaptic cytosolic calcium produced by activity-dependent opening of voltage-gated calcium channels (Castillo et al., 2012; Kano, 2014) . In the brain, 2-AG is the dominant endocannabinoid (Alger and Kim, 2011) , and its best-known actions are as a retrograde messenger, traversing the postsynaptic cell membrane to activate G i/o -protein-coupled cannabinoid type 1 (CB 1 ) receptors at presynaptic terminals and produce suppression of neurotransmitter release (Kreitzer and Regehr, 2001; Ohno-Shosaku et al., 2001; Wilson and Nicoll, 2001 ). In some neurons, 2-AG can reduce excitability by cell-autonomous actions mediated by receptors in the postsynaptic membrane, via CB 1 (Bacci et al., 2004; Marinelli et al., 2008; , or CB 2 receptors (den Boon et al., 2014; Stempel et al., 2016) . Most neuronal actions of 2-AG require CB receptors, with CB 1 receptors mediating the vast majority of actions in the brain . However, arachidonic acid (AA), the fatty acid moiety of 2-AG, has no activity at either CB 1 or CB 2 receptors yet can regulate neuronal function (Oliver et al., 2004; Carta et al., 2014) by directly modifying gating of several types of voltage-dependent potassium channels (reviewed by Meves, 2008) . As AA-containing molecules, anandamide and 2-AG can in principle also act in a CB receptor-independent manner, entering the membrane bilayer and directly modifying gating of ion channels (Oz, 2006; Pertwee, 2015) . Indeed, in heterologous systems, 2-AG can directly activate TRPV1 channels (Zygmunt et al., 2013) and allosterically modulate GABA A and glycine receptor channels (Lozovaya et al., 2011; Sigel et al., 2011) . 2-AG can also modify gating of cloned cardiac Kv4.3 channels (Amoró s et al., 2010) and was recently shown to endogenously control gating of the CatSper cation channel in human sperm through lipid interactions (Miller et al., 2016) . Despite the wealth of literature on endocannabinoid-dependent synaptic plasticity, direct effects of endocannabinoids on ion channels have mainly been characterized in cloned channels and non-neuronal tissues. The possible role of this mode of endocannabinoid signaling in controlling excitability of neurons has received little attention.
We explored whether 2-AG can regulate the firing activity of midbrain dopamine neurons through CB receptor-independent mechanisms. Midbrain dopamine neurons are well suited for this purpose, because immunohistochemistry suggests that they lack expression of CB 1 receptors (Herkenham et al., 1991; Má tyá s et al., 2008) and an abundance of evidence shows that they synthesize (Má tyá s et al., 2008) and release 2-AG, which acts in a retrograde manner to strongly regulate both glutamatergic (Kortleven et al., 2012; Labouè be et al., 2013; Melis et al., 2004a Melis et al., , 2004b and GABAergic (Melis et al., 2014; Pan et al., 2008; Riegel and Lupica, 2004; Tung et al., 2016; Wang et al., 2015) inputs. To isolate direct effects on intrinsic excitability from synaptically mediated effects, we used a preparation of acutely dissociated midbrain dopamine neurons, which retain their distinctive electrophysiological properties, including regular pacemaking (Hainsworth et al., 1991; Puopolo et al., 2007) . We found a robust acceleration of action potential firing by 2-AG at concentrations as low as 100 nM, mediated at least in part by reduction of A-type potassium current. These effects were reproduced by AA, consistent with a direct effect involving lipid modulation of potassium channel gating.
RESULTS

2-AG Speeds Action Potential Firing in Midbrain Dopamine Neurons
At 37 C, using acutely isolated dopamine neurons from the substantia nigra pars compacta (SNc) of mice, we found that (F) Plot of initial firing frequency (first three APs) versus injected current in control (black) and 100 nM 2-AG (red); means ± SEM, linear fit from 0 to 100 pA indicates mean F-I slope. (G) F-I slopes for each cell, determined by linear fit from 0 to 100 pA, showing the increase by 2-AG (p = 0.002, n = 10). Wash solution contained 1 mg/mL BSA for rapid reversibility. In some experiments, control solution also contained BSA. * denotes statistical significance.
application of 2-AG at 100 nM accelerated spontaneous firing from 6.9 ± 0.7 Hz to 9.5 ± 1.0 Hz (p < 0.001, n = 15, Figures 1A and 1B) . The effect of 100 nM 2-AG on firing developed in less than a second and reversed similarly quickly ( Figure 1A ) when control Tyrode's solution contained 1 mg/mL bovine serum albumin to sequester the 2-AG.
In addition to tonic slow pacemaking, dopamine neurons fire higher-frequency bursts of APs when natural reward, drugs of abuse, or reward-predictive cues drive glutamatergic synaptic input (Paladini and Roeper, 2014) . In dissociated dopamine neurons, somatic current injection (500 ms, 20 pA, Figures 1C  and 1E ) evoked AP firing at frequencies of 7-36 Hz, similar to AP bursts in behaving mice (Cohen et al., 2012) . Application of 2-AG (100 nM) increased the frequency of evoked firing, calculated from the first three APs, from 17.6 ± 1.7 Hz to 22.4 ± 2.0 Hz (p < 0.001, n = 15, Figures 1C-1E ). 2-AG increased the frequency of evoked firing for all levels of injected current and resulted in an increased slope of the frequency versus injected current relationship (F-I curve, p = 0.002, n = 10, Figures 1F  and 1G ). Thus, 2-AG produces increased excitability of dopamine neurons over the full extent of their firing range. Figure 2A illustrates APs during spontaneous firing recorded in the same cell in control and in 2-AG (100 nM), with signal-averaged APs aligned at their peak to illustrate changes in AP shape and the firing cycle. 2-AG had no significant effect on AP width (measured at midpoint between the peak and trough) of either spontaneous APs (p = 0.85, n = 15, Figure 2B ) or evoked APs (measured from the first AP, p = 0.98, n = 15). However, 2-AG decreased the afterhyperpolarization (AHP, measured at the trough following the AP) by an average of 2.8 ± 0.4 mV (p < 0.001, n = 15, Figure 2C ). 2-AG also significantly increased the slope of the depolarization between APs during both spontaneous and evoked firing (interspike slope, measured in the middle 60% of the interspike interval, p < 0.001, n = 15, Figures 1D,  2A , and 2D). Thus, 2-AG speeds firing in synaptically isolated dopamine neurons by reducing the AHP and increasing the rate of depolarization between action potentials.
2-AG Inhibits A-type Potassium Current and Speeds Inactivation
Subthreshold inactivating A-type potassium current (I A ) facilitates slow rhythmic firing by activating and inactivating between action potentials. Midbrain dopamine neurons have prominent somatodendritic I A carried by Kv4.3 channels (Liss et al., 2001; Serô dio and Rudy, 1998) . The magnitude of I A expression is inversely correlated with spontaneous firing rate and reduction of I A speeds AP firing (Amendola et al., 2012; Hahn et al., 2003; Liss et al., 2001; Subramaniam et al., 2014) . To determine whether 2-AG affected I A , we activated I A by a step from À108 to À28 mV in whole-cell voltage-clamp mode ( Figure 3A ). Application of 2-AG (100 nM) reduced the peak amplitude of I A , by an average of 20.1% ± 2.7% (p = 0.001, n = 11, Figures 3A-3C ). Higher concentrations of 2-AG produced greater inhibition of I A . At 30 mM, 2-AG inhibited peak I A by 82.2% ± 2.1% (p = 0.02, n = 7, Figure 3C ). At all concentrations tested (30 nM-30 mM) the inhibition in peak I A amplitude was significant ( Figures 3A-3C ). In addition to reducing peak amplitude, 2-AG accelerated the inactivation kinetics of I A . The dominant inactivation time constant of I A (t fast ) was decreased with 2-AG: by 37.0% ± 4.7% at 100 nM, 59.4% ± 3.4% at 1 mM, and 82.0% ± 1.2% at 10 mM 2-AG ( Figure 3D ).
To determine whether the changes in firing produced by 2-AG are consistent with reduction of I A , we compared them with effects produced by the Kv4 inhibitor AmmTx3 (Vacher et al., 2002; Amendola et al., 2012) . Application of 10 nM AmmTx3 inhibited I A amplitude by 24.4% ± 4.8% ( Figure S1A ), similar to the $20% inhibition of I A by 100 nM 2-AG. The effects of 10 nM AmmTx3 on firing of dopamine neurons were very similar to those of 100 nM 2-AG ( Figure S1B ): an increase in spontaneous firing frequency (p = 0.016, n = 8, Figure S1C ) accompanied by a decreased AHP (p = 0.008, n = 8 Figure S1D ) with no significant change in AP width (p = 0.11, n = 8, Figure S1E ). The interspike slopes of spontaneous and evoked firing were increased by AmmTx3 (p = 0.016, n = 8; Figure S1F ), similar to the changes produced by 2-AG. These results demonstrate the sensitivity of pacemaking to reduction of A-type potassium conductance by 20%-25%.
Previous work assessed the net ionic current between APs using voltage ramps that mimic the interspike slope and showed that I A is active at subthreshold potentials between APs (Khaliq and Bean, 2008) . We mimicked the activation of I A between spikes by using voltage ramps delivered at a range of speeds ( Figure S2A ) encompassing the rate of interspike depolarization during both spontaneous and evoked firing (measured in Figure 2D ). Figure S2B shows an example of I A activated by 5 ramp speeds (60, 150, 300, 600, and 900 mV/s) in control and after application of 2-AG (100 nM) in the same cell. The amplitude of I A measured at À50 mV was smaller for slower ramp speeds, reflecting subthreshold inactivation from closed states of the channel (Jerng et al., 2004 ). 2-AG (100 nM) inhibited ramp-evoked I A at subthreshold potentials at all ramp speeds (p < 0.001 for all ramp speeds, n = 16, Figure S2C ).
2-AG Shifts the Voltage Dependence of Activation of A-type Potassium Current
Next, we examined the effects of 2-AG on the voltage dependence of I A activation by constructing conductance-voltage plots. The voltage dependence of I A channel activation could be fit well by a Boltzmann function ( Figures 4A-4C ). In control, the average midpoint of activation (V h ) was À40.7 ± 0.7 mV, with a slope factor of 7.7 ± 0.3 mV, and a maximum conductance of 137.7 ± 5.6 nS (n = 46). At 30 nM, 2-AG significantly reduced the maximum conductance (p < 0.02, n = 8) without significant effect on the midpoint. At higher concentrations, 2-AG caused a rightward shift in the activation of I A ( Figures 4B-4E ). At 300 nM, 2-AG shifted V h by +4.6 ± 1.4 mV (p = 0.016, n = 7) and at 10 mM, the shift in V h increased by +24.6 ± 2.1 mV (p < 0.001, n = 12, Figures 4D and 4E ). Thus, 2-AG inhibited maximal conductance at all 2-AG concentrations, with an additional effect of shifting activation at higher concentrations. A characteristic of Kv4 channel-mediated somatodendritic I A is the development of inactivation at subthreshold voltages before any appreciable channel opening (Jerng et al., 2004) . To determine whether 2-AG affected a closed-to-inactivated state transition, we held cells at conditioning potentials that induce little or no channel opening (200 ms) before activating I A with a step to À38 mV. The relationship between the conditioning potential and I A amplitude activated at À38 mV was plotted and fit with a Boltzmann function. In control, inactivation had a midpoint of À75.3 ± 0.5 mV, with a slope factor of 4.2 ± 0.05 mV (n = 49). At concentrations from 30 nM to 3 mM, 2-AG had no significant effect on steady-state inactivation ( Figure S3 ). At 10 mM, 2-AG caused a À4.3 ± 1.3 mV shift in the voltage dependence of steady-state inactivation (p = 0.01, n = 11, Figure S2 ). Thus, although inactivation kinetics became faster in the presence of 2-AG when measured at voltages with significant channel activation, the voltage dependence of steady-state inactivation at voltages without substantial channel activation was not affected except at the highest 2-AG concentrations.
Cannabinoid Receptor-Independent Mechanism of 2-AG Immunostaining indicates that midbrain dopamine neurons do not abundantly express CB 1 receptors (Herkenham et al., 1991; Má tyá s et al., 2008) , but expression of CB 2 receptors has been demonstrated (Zhang et al., 2014) . To determine whether the action of 2-AG on I A involved cannabinoid receptors (CB-R), we exposed cells to a variety of CB 1 and CB 2 antagonists and inverse agonists prior to the application of 2-AG. Figure 5A shows an example of the effect of 2-AG on I A tested in the pres- 
2-AG Inhibits A-type Potassium Current
(A) Left: current evoked by a voltage step from À108 to À28 mV, in control Tyrode's solution (black) and after 100 nM 2-AG (red). I A was measured as the peak of the rapidly inactivating component. Right: I A shown on an expanded timescale with application of 100 nM (red), 1 mM (green), or 10 mM (blue) 2-AG (three different experiments). (B) I A was activated as in (A), once every 5 s. Normalized plot of I A amplitude versus time during application of 100 nM (red, n = 11), 1 mM (green, n = 7), and 10 mM (blue, n = 34) 2-AG, means ± SEM. (C) 2-AG inhibited I A in a concentration-dependent manner, (30 nM: p = 0.004, n = 9; 100 nM: p = 0.001, n = 11; 300 nM: p = 0.001, n = 11; 1 mM: p = 0.02, n = 7; 3 mM: p = 0.02, n = 7; 10 mM: p < 0.001, n = 34; 30 mM: p = 0.02, n = 7), means ± SEM. (D) 2-AG decreased the inactivation time constant of I A (t fast , determined by a single exponential fit) in a concentration-dependent manner, shown relative to t fast in control (100 nM: p = 0.001, n = 11; 1 mM: p = 0.02, n = 7; 10 mM: p < 0.001, n = 33), means ± SEM. See also Figures S1 and S2.
ence of the CB 1 and CB 2 inverse agonists, AM251 (1 mM) and AM630 (1 mM). In the presence of AM251 and AM630, 2-AG decreased the peak amplitude of I A (p < 0.001, n = 13, Figures 5A , 5B, and 5D) and sped inactivation kinetics (p < 0.001, n = 12, Figures 5A and 5C), just as in control conditions. In collected results, the average magnitude and time course of I A inhibition by 2-AG presented in AM251 and AM630 were indistinguishable from the effects in control ( Figure 5A ). Also, exposure to AM251 and AM630 did not affect the rightward shift in the voltage dependence of activation induced by 3 mM 2-AG (p = 0.79, n = 5-6, Figure 5E ). Similar results were obtained in the presence of the highly potent and selective CB 1 receptor antagonist, NESS 0327 (1 nM), the selective CB 2 receptor inverse agonist SR 144528 (10 nM), or both NESS 0327 and SR 144528 ( Figures 5D and 5E ). Interestingly, we found that all of the CB-R antagonists and inverse agonists had direct, concentration-dependent inhibitory effects on I A , with statistically significant inhibition of 20% ± 5% by the combination of 1 mM AM251 and 1 mM AM630 (n = 13), 26% ± 5% by 1 nM NESS 0327 (n = 11), and 15% ± 5% by 10 nM SR 144528 (n = 11) (data not shown). As the agents had no significant effect on subsequent effects of 2-AG, this direct pharmacological effect did not affect our conclusion that 2-AG effects are independent of CB-Rs but is an important consideration when using these compounds in other contexts.
As a broader test of whether the effects of 2-AG are mediated by G-protein-coupled receptors, we performed a series of experiments applying 2-AG to cells dialyzed with an internal solution containing the non-hydrolyzable GDP analog GDPbS (1.8 mM). 2-AG (10 mM) produced robust inhibition (66.7% ± 2.8%) of I A in cells dialyzed with GDPbS, with no diminution of the response over periods of up to 20 min after the start of dialysis (n = 6, Figure 5F ). With similar recording conditions, GDPbS nearly completely blocks G-protein-mediated effects such as activation of GIRK current (Sodickson and Bean, 1996) and CB 2 -mediated modulation of the sodium bicarbonate cotransporter (Stempel et al., 2016) within $5-6 min. Thus, the effects of exogenous 2-AG on I A do not require activation of G proteins, consistent with being independent of CB 1 or CB 2 receptors.
Endocannabinoids and structurally related fatty acids can modify gating of voltage-gated ion channels, independent of CB-Rs, through membrane lipid interactions (Amoró s et al., 2010; Carta et al., 2014; Lishko et al., 2010) . Arachidonic acid (AA), the fatty acid moiety of 2-AG, has no agonistic properties or affinity for CB 1 or CB 2 receptors (Sugiura et al., 1995 (Sugiura et al., , 2000 but might mimic receptor-independent effects of 2-AG. Indeed, AA had effects nearly identical to those of 2-AG. Application of AA (100 nM) accelerated the frequency of spontaneous firing (p < 0.01, n = 7, Figures 6A and 6B ) and of evoked firing (calculated from the first three APs, p < 0.05, n = 7, Figures 6A and 6C ) and increased the slope of the F-I curve (p < 0.05, n = 7, Figure 6D) . In whole-cell voltage-clamp mode, application of AA (100 nM) reduced the peak amplitude of I A by 32.9% ± 3.2% (p = 0.001, n = 11, Figures 6E and 6F ) and accelerated the inactivation kinetics of I A (p = 0.002, n = 11, Figure 6G ).
Since 2-AG may be metabolized to AA by monoacylglycerol (MAG) lipase, we examined the effect of 2-AG on I A after MAG lipase inhibition. Brain slices were incubated with the MAG lipase inhibitor JZL184 (30 nM) prior to dissociation for >50 min, which inhibits >95% of recombinant MAG lipase and blocks $85% of 2-AG hydrolysis in brain membranes (Long et al., 2009) . After incubation and in the continued presence of JZL184, application of 2-AG (10 mM) reduced the amplitude of I A by 56.0% ± 3.1% (p < 0.001, n = 18, Figure S4 ). The reduction in I A by 2-AG after MAG lipase inhibition was 14% less than in control Tyrode's (p < 0.001, ns = 34 and 18, Figure S4 ). These data suggest that MAG lipase-mediated metabolism of 2-AG is not required for the inhibition of I A , but the diminished effect is consistent with additional involvement of arachidonic acid or structurally related 2-AG metabolites (c.f. Blankman et al., 2007) .
The effects of lipid interactions of polyunsaturated fatty acids can be reversed with external solution supplemented with fatty acid-free bovine serum albumin (BSA) (Boland et al., 2009; Holmqvist et al., 2001; Lishko et al., 2010; Poling et al., 1996; Villarroel and Schwarz, 1996) , reflecting the ability of BSA to bind and extract 2-AG and related fatty acids from the membrane (Beck et al., 1998; Bisogno et al., 1997) . To determine whether the effect of 2-AG involves lipid interactions, we examined the reversibility of its effects by BSA. With Tyrode's solution, the inhibition of I A and acceleration in inactivation kinetics produced by 2-AG (10 mM) were poorly reversible ( Figures 7A-7C) . However, the effects of 2-AG were reversed readily when BSA (1 mg/mL) was included in the external Tyrode's solution ( Figures 7A-7C , also see Figures 1, 5F, and 6 further demonstrating the reversibility of 2-AG and AA on I A inhibition and enhanced excitability). These results are consistent with the effect of 2-AG on A-type potassium current resulting from a direct action on the channel through a membrane lipid interaction.
Interestingly, BSA alone (without prior 2-AG exposure) produced an enhancement in I A amplitude (25.6% ± 2.6%, p < 0.001, n = 13, Figures S5A, S5B, and S5I) and a slowing of inactivation kinetics (1.64 ± 0.1 relative t fast , p < 0.001, n = 13, Figures S5A, S5C, and S5J) . BSA also produced a significant slowing of pacemaking (p = 0.02, n = 12) and a decrease in the interspike slope (p = 0.01, n = 12, Figures S5D-S5F ). These results suggest that there may be some basal modulation of I A by endogenous 2-AG or similarly acting lipid effectors that can be stripped by BSA. To test whether the effects can be attributed to 2-AG, we (A) I A in control Tyrode's solution (black) and with 1 mM 2-AG (green). I A was isolated using a two-pulse voltage protocol, first evoking total potassium current by 500 ms steps from À88 mV, then inactivating I A by a 500 ms step to À58 mV preceding a second 500 ms test step, with I A obtained by subtracting currents during the two test steps. (B-D) Conductance was determined from the peak I A evoked from a holding potential of À88 mV, calculated using a reversal potential of À90 mV. Solid lines represent fit of the data to a Boltzmann function. (B and C) Change in conductance-voltage relationship by 1 mM 2-AG (B, green) or 10 mM 2-AG (C, blue). (D) Normalized conductance-voltage plots demonstrating the rightward shift in I A activation in 1 mM (green) or 10 mM 2-AG (blue) relative to control (black), means ± SEM. (E) 2-AG (300 nM-10 mM) produced a significant rightward shift in the average midpoint of activation (V h, ns = 6-12), means ± SEM, * denotes statistical significance. See also Figure S3. applied the diacylglycerol lipase a (DGLa) inhibitor tetrahydrolipstatin (THL) to prevent synthesis of 2-AG (100 nM, >50 min exposure of the brain slices prior to dissociation of neurons). Both the enhancement of I A and slowing of inactivation kinetics by BSA were prevented by pre-incubation in THL (amplitude: p = 0.24, n = 11, Figures S5H-S5J ). In fact, following pre-incubation in THL, BSA alone accelerated I A inactivation kinetics slightly (p = 0.003, n = 11). This suggests that the effects of BSA reflect stripping of basally active 2-AG or 2-AG-derived compounds.
Reduction of I A by Action Potential-Induced Calcium Entry
In some brain regions, production of 2-AG can be triggered by calcium entry (Brenowitz and Regehr, 2003; Kano, 2014) . We explored whether calcium entry evoked by neuronal firing could produce the effects associated with 2-AG. In dopamine neurons, block of small-conductance calcium-activated potassium channels (SK) increases spontaneous firing of dopamine neurons by >5-fold, promotes burst firing, and mobilizes endocannabinoids (Riegel and Lupica, 2004) . Brain slices were treated with the SK channel blocker apamin (100 nM, 10-20 min, 24 C) prior to dissociation, and the effects of external BSA on single cells was assessed within 50 min. After apamin treatment, BSA produced a greater enhancement of I A amplitude (50.2% ± 3.0%, p < 0.001) and slowing of inactivation kinetics (2.3 ± 0.2 relative t fast , p = 0.009) relative to control (n = 11, Figures S5G, S5I , and S5J). These results suggest that increased neuronal activity affects basal lipid-dependent modulation of I A , but it is difficult to attribute this effect solely to dopamine neuron firing since the neurons were not isolated from synaptic input during apamin exposure. To assess whether dopamine neuron firing at physiologically relevant frequencies could stimulate endogenous 2-AG modulation of I A in a cellautonomous manner, we tested whether bursts of action potentials applied to the neuron as a voltage-clamp command resulted in inhibition of I A . There was no obvious effect on I A of single bursts of high-frequency firing (16 action potentials at 32 Hz). However, repeated bursts of firing (16 APs at 32 Hz per burst, one burst every 5 s for 2 min) resulted in a small reduction of I A (12.0% ± 2.6%, p = 0.004, n = 9; Figure S6 ). This effect was not observed when the protocol was performed in BSA, consistent with being mediated by 2-AG or other lipid mediator sensitive to stripping by BSA.
Mobilization of Endogenous 2-AG by G q/11 -Coupled Receptors Inhibits A-type Potassium Current In dopamine neurons, activation of G q/11 -protein-coupled glutamate (mGluR), neurotensin, or orexin receptors effectively mobilizes 2-AG through activation of phospholipase C (PLC) (Kortleven et al., 2012; Melis et al., 2004a Melis et al., , 2004b Pan et al., 2008; Riegel and Lupica, 2004; Tung et al., 2016; Wang et al., 2015) . We therefore tested whether the effects of exogenous 2-AG could be mimicked by activating G q/11 PCRs. Application of the mGluR agonist DHPG (10 mM), orexin A (OrxA, 1 mM), and neurotensin (NT, 100 nM) each caused significant inhibition of I A (Figures 8A and 8F ). The inhibition produced by DHPG was unaffected by CB 1 or CB 2 receptor block by NESS 0327 and SR 144528, respectively (p = 0.09, ns = 10 each, Figure S7 ). But the inhibition produced by each G q/11 PCR agonist was prevented by co-application of BSA ( Figures 8B, 8E , and 8F), consistent with mediation by 2-AG or another fatty acid-based modulator. To determine whether the production of 2-AG was required, we first exposed cells to THL (100 nM) to block synthesis of 2-AG. In the presence of THL, DHPG, OrxA, and NT, each failed to inhibit I A ( Figures 8C, 8E , and 8F). However, exogenous 2-AG (3 mM) still significantly inhibited I A in the presence of THL (69.5 ± 2.9%, p = 0.03, n = 6, data not shown). To determine whether activation of PLC was required for the effects of G q/11 PCR activation, we first dialyzed cells with internal solution containing the PLC inhibitor U73122 (1 mM). With intracellular U73122, DHPG failed to reduce I A (p = 0.69, n = 6, Figures 8D-8F ). OrxA and NT produced modest inhibition of I A with intracellular U73122, but the magnitude of the inhibition was significantly less than the inhibition produced in control (OrxA: p = 0.01, n = 6; NT: p = 0.01, n = 6, Figures   8D and 8F ). Taken together, these results suggest that activation of mGluR, orexin, or neurotensin G q/11 -protein-coupled receptors reduce the magnitude of A-type potassium current primarily by the production of 2-AG ( Figure 9 ). DISCUSSION 2-AG Increases Intrinsic Excitability 2-AG is the major endocannabinoid in the brain. Our experiments show that in addition to the many known effects of 2-AG mediated by CB receptors, 2-AG acts directly on I A channels and enhances excitability of dopamine neurons. Isolation of cell-autonomous actions of 2-AG was made possible by studying isolated dopamine neurons, where possible mediation by pathways involving neighboring neurons or glial cells can be ruled out.
2-AG Modulation of I A and Firing
Previous work has shown that I A is an especially sensitive locus for controlling firing of midbrain dopamine neurons. The magnitude of I A in individual neurons is strongly correlated with pacemaking frequency (Liss et al., 2001) , and homeostatic upregulation of I A slows pacemaking (Hahn et al., 2003 (Hahn et al., , 2006 . In models of dopamine neuron pacemaking, I A is the dominant potassium current flowing during the interspike interval (Kuznetsova et al., 2010) , consistent with experimental measurements (Khaliq and Bean, 2008) . Acute partial inhibition of I A by toxins speeds pacemaking (Liss et al., 2001; Amendola et al., 2012; Subramaniam et al., 2014) and dynamic clamp enhancement of simulated I A effectively slows it (Putzier et al., 2009 ). I A in dopamine neurons can be controlled by other signaling pathways, including In some experiments, control solution also contained BSA. (E) I A activated by a voltage step from À108 to À28 mV in control (black) and after application of AA (100 nM, red). (F) 100 nM AA significantly inhibited the amplitude of I A (p = 0.001, n = 11) shown with 2-AG (100 nM) data from Figure 3C to aid visual comparison. (G) 100 nM AA decreased the inactivation time constant of I A (t fast , determined by a single exponential fit, p = 0.002, n = 11) relative to t fast in control, shown with 2-AG (100 nM) data from Figure 3D to aid visual comparison. * denotes statistical significance. See also Figure S4 . redox modulation (Roeper and Ashcroft, 1994; Subramaniam et al., 2014) .
Given the sensitivity of pacemaking frequency to I A , reduction of interspike I A likely accounts for most of the acceleration of pacemaking produced by 2-AG. Indeed, comparable reductions in I A produced by AmmTx3 produced similar changes in AP firing rate. Nonetheless, there could well be additional conductances modulated directly by 2-AG. Although reduction of inactivating I A was the most striking effect, 2-AG also reduced a slow component of tail current at À48 mV ( Figure 3A ) that likely originates from Kv2 channels, which help control evoked higher firing frequency and the slope of the F-I curve (Kimm et al., 2015) . Also, 2-AG often produced a small (typically $5 pA) inward shift of current at voltages too negative for activation of I A (À88 mV). Further work will be needed to determine the molecular basis of this conductance.
Mechanism of I A Inhibition by 2-AG
We find that 2-AG modulates I A in three ways: shifting activation in the depolarizing direction, speeding inactivation, and reducing the maximal current for large depolarizations. The voltagesensing region of ion channels is intimately connected to and influenced by interacting lipids (Swartz, 2008) , so it is easy to envision that the powerful control of channel function by polyunsaturated fatty acid-based modulators like 2-AG and arachidonic acid (Boland et al., 2009; Meves, 2008; Oliver et al., 2004; Villarroel and Schwarz, 1996) reflects direct interactions with the gating machinery of the channel protein. In cloned Kv4.2 channels, inhibition by arachidonic acid is sensitive to mutations in the intracellular loop between the S4 and S5 transmembrane regions (Villarroel and Schwarz, 1996) , which interacts with the S6 region to mediate inactivation (B€ ahring et al., 2012) . Binding of 2-AG or arachidonic acid may modify the interaction of the voltage-sensing S4-S5 region with the S6 region that controls channel opening and closing.
In SNc dopamine neurons, I A is mediated by Kv4.3 channels in combination with KChIP3.1 accessory subunits (Liss et al., 2001) . The modulation of native I A in dopamine neurons by 2-AG was generally similar to that of cloned Kv4.3 channels expressed with KChIP2 (Amoró s et al., 2010) except that 1 mM 2-AG shifted the voltage dependence of inactivation of cloned Kv4.3/KChIP2 channels in the hyperpolarizing direction, an effect we saw only at higher concentrations (>3 mM), possibly reflecting differential effects conferred by the different KChIP proteins. The effects of 2-AG on gating of native Kv4-mediated I A in dopamine neurons differ from those previously described for arachidonic acid inhibition of potassium current in presynaptic mossy fiber terminals (Carta et al., 2014) , likely mainly Kv1 and Kv3 channels (Geiger and Jonas, 2000; Alle et al., 2011) , where inhibition involves a hyperpolarizing shift of inactivation without a change in activation.
Our experiments explored acute effects of 2-AG occurring within seconds and evident at 2-AG concentrations as low as 30 nM. With chronic (12 hr) exposure to high concentrations of 2-AG (10 mM), there is apparent upregulation of expression of I A in cultured caudate nucleus neurons (Zou et al., 2016) . This may be a compensatory response to inhibition of I A , consistent with other situations in which expression levels of Kv4 channels are altered by long-term changes in neuronal activity (Hahn et al., 2003 (Hahn et al., , 2006 .
Physiological Significance
Extensive previous work has shown that activation of G q/11 -coupled receptors in dopamine neurons stimulates 2-AG formation and retrograde modulation of synaptic transmission (Kortleven et al., 2012; Melis et al., 2004a Melis et al., , 2004b Melis et al., , 2014 Pan et al., 2008; Riegel and Lupica, 2004; Tung et al., 2016; Wang et al., 2015) . In our experiments, activating mGluR, orexin, or neurotensin receptors rapidly inhibited I A by 20%-35% and mimicked the magnitude of effects of 100 nM-1 mM exogenous 2-AG. The inhibition of I A by G q/11 -coupled receptor activation was prevented by perfusion with BSA and by blocking synthesis of 2-AG by inhibiting PLC or DAG lipase. Therefore, endogenously mobilizing 2-AG can inhibit I A within the same cell. A recent study conducted on dorsal raphe serotonin neurons in brain slices also reported that orexin reduced I A by $20% in a PLC-dependent manner (Ishibashi et al., 2016) , suggesting that 2-AG regulation of I A and neuronal excitability may not be confined to dopamine neurons. In some neurons, 2-AG generation can be effectively stimulated by an increase in intracellular calcium resulting from repetitive firing (Bacci et al., 2004; Marinelli et al., 2008 Marinelli et al., , 2009 . Consistent with such a mechanism in dopamine neurons, we found that tonic lipid-dependent modulation of I A in isolated neurons was enhanced by prior, albeit non-physiological, increases in network excitability by treated brain slices with apamin. In isolated neurons, repetitive bouts of action potential bursts inhibited I A through a mechanism blocked by BSA. However, this effect required repeated bouts of burst firing and developed much more slowly than the effects of stimulation of G q/11 -coupled receptors, consistent with results in other cell types in which stimulation of 2-AG formation by calcium entry alone requires high levels of intracellular calcium (Brenowitz and Regehr, 2003; Regehr et al., 2009 ) and cases in which calcium entry requires concurrent activation of G q/11 -coupled receptors for substantial 2-AG generation Kano et al., 2009; Maejima et al., 2005) , as has been described in dopamine neurons (Melis et al., 2004a) . Similarly, the weak effects of repeated burst firing compared to application of 100 nM arachidonic acid suggest that generation of arachidonic acid by potential pathways involving spike-evoked calcium entry is much weaker in dopamine neurons than in hippocampal CA3 pyramidal neurons, where lower levels of action potential firing are effective at producing effects mediated by arachidonic acid and related metabolites (Carta et al., 2014) . Weak activation of 2-AG or arachidonic acid formation by activity-evoked intracellular calcium in dopamine neurons is logical, because these neurons are unusual in using a mechanism of pacemaking involving continual entry of calcium. A powerful pathway for calciumevoked generation of 2-AG or arachidonic acid and speeding of firing would constitute a potentially deleterious positive feedback pathway. Instead, our experiments show that this pathway is only weakly activated by activity-dependent calcium entry but much more robustly by G q/11 -coupled receptors, with which dopamine neurons are well endowed.
In studies on cultured cell lines where 2-AG concentrations can be well defined, 2-AG activates CB 1 or CB 2 receptors with EC 50 s of 40 nM-1.5 mM (Ben-Shabat et al., 1998; Gonsiorek et al., 2000) . However, in brain slice experiments, mimicking CB-R-mediated synaptic plasticity induced by endogenous 2-AG requires 10-30 mM exogenous 2-AG (e.g., Bacci et al., 2004; den Boon et al., 2014; Marinelli et al., 2008 Marinelli et al., , 2009 Wilson and Nicoll, 2001 ). This discrepancy is likely due to the difficulty of applying such hydrophobic compounds that readily partition non-specifically into membranes on the entire brain slice. In our experiments, the use of acutely dissociated neurons facilitated the rapid application of well-defined 2-AG concentrations. Inhibition of I A by 2-AG was evident at concentrations as low as 30 nM, suggesting that direct modulation of native I A is equally sensitive as CB receptor-mediated effects. 2-AG is believed to exert retrograde effects by either diffusing across the postsynaptic membrane or by passive transport involving a fatty acid transporter (Alger and Kim, 2011) , implying that 2-AG levels in the postsynaptic membrane, where 2-AG is generated, are likely considerably higher than those reached at CB receptors in the presynaptic membrane. Indeed, in some neurons, production of 2-AG reduces excitability in an autocrine manner, mediated by CB receptors in the postsynaptic membrane (Bacci et al., 2004; den Boon et al., 2014; Marinelli et al., 2008 Marinelli et al., , 2009 Stempel et al., 2016) . Our study utilized three separate G q/11 receptors known to produce 2-AG-dependent effects on synaptic plasticity in dopamine neurons and the results demonstrate that endogenously mobilizing 2-AG reduced I A . In combination with the potent effects of exogenously applied 2-AG, it therefore seems very likely that 2-AG levels sufficient to produce retrograde effects would also produce robust modulation of I A in dopamine neurons under physiological conditions, although this remains to be tested directly.
Because the effects of 2-AG on I A are mimicked by arachidonic acid, they should last longer than those mediated by CB receptors, which are terminated by the relatively rapid breakdown of 2-AG (Hashimotodani et al., 2007; Melis et al., 2014; Tung et al., 2016; Wang et al., 2015) . Another important difference is that unlike CB receptor-mediated effects, direct effects of endocannabinoids on channels will generally not be mimicked by synthetic small-molecules or plant-derived cannabinoids acting through CB receptors, which may help explain CB receptor-independent behavioral effects of endocannabinoids (e.g., Di Marzo et al., 2000; Lichtman et al., 2002) .
Endocannabinoid Control of Dopamine Neuron Function
The activity of midbrain dopamine neurons coordinates reward-associated behaviors through the release of dopamine. Previous work has shown that 2-AG released from dopamine neurons acts as a retrograde messenger, activates presynaptic CB receptors, and reduces both excitatory and inhibitory input to dopamine neurons (Kortleven et al., 2012; Labouè be et al., 2013; Melis et al., 2004a Melis et al., , 2004b Melis et al., , 2014 Pan et al., 2008; Riegel and Lupica, 2004; Tung et al., 2016; Wang et al., 2015) . Endocannabinoids enhance dopamine release from axon terminals in vivo (Wang et al., 2015) , suggesting a net excitatory change, to which direct reduction of I A may contribute by enhancing firing frequency and dendritic excitability (Gentet and Williams, 2007) . The action of elevated levels of extracellular dopamine may be prolonged by reduced dopamine clearance by endocannabinoids and arachidonic acid (Oz et al., 2010) .
In cortical interneurons and pyramidal neurons, 2-AG acts via CB 1 receptors to produce cell-autonomous inhibition via activation of G i / o and G-protein-coupled inward rectifying potassium (GIRK) channels (Bacci et al., 2004; Marinelli et al., 2008 Marinelli et al., , 2009 . Dopamine neurons have robust activation of GIRK channels by GABA B and D 2 receptors but not detectable levels of CB 1 receptors (Herkenham et al., 1991; Má tyá s et al., 2008) , explaining why this pathway is not present.
Our results show that 2-AG inhibits I A in dopamine neurons independent of cannabinoid receptors and that cell-autonomous inhibition of I A occurs when 2-AG is mobilized by activating G q/11 -linked receptors including orexin, neurotensin, and mGluR receptors. Thus, the effects of endocannabinoids on dopamine neurons in a physiological context likely include enhancement of intrinsic excitability in addition to the previously known CB receptor-dependent modulation of synaptic input from excitatory and inhibitory synapses.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact Bruce P. Bean (bruce_bean@hms.harvard.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
All studies followed procedures approved by the Institutional Animal Care and Use Committee of Harvard Medical School. Wild-type Swiss Webster mice (16-22 days old) of either sex were used. Mice were group-housed with the dam and littermates in standard plastic containers and were on a 12-h light/dark cycle. Food and water were available ad libitum.
METHOD DETAILS Slice Preparation and Acute Dissociation
Mice were deeply anesthetized with isoflurane and killed by decapitation. Brains were removed quickly and placed in ice-cold HEPES-sucrose cutting solution containing (in mM): 110 NaCl, 2.5 KCl, 7.5 MgCl 2 , 10 HEPES, 25 glucose, and 75 sucrose with 1 mM kynurenic acid to reduce excitotoxicity and increase viability, pH adjusted to 7.4 with NaOH and bubbled with 95/5% O 2 / CO 2 . In the same solution, horizontal midbrain slices (250 mm) were obtained using a vibrating microtome (Campden Instruments, Ltd.) and visualized under 3x magnification. Then, the substantia nigra pars compacta (SNc, lateral to the medial terminal nucleus of the accessory optic tract) was microdissected out and rinsed in dissociation solution containing (in mM): 82 Na 2 SO 4 , 30 REAGENT K 2 SO 4 , 5 MgCl 2 , 10 HEPES, 10 glucose, 1 kynurenic acid, pH adjusted to 7.4 with NaOH. SNc-containing tissue pieces were incubated for 12 min at 27 C in 3 mg/mL protease XXIII (Sigma-Aldrich) dissolved dissociation solution. Following enzymatic treatment, the pieces were transferred to 27 C dissociation solution containing trypsin inhibitor (1 mg/mL) and BSA (1 mg/mL), which were then placed on ice and stored until use. Prior to recording, a tissue piece was transferred to 24 C Tyrode's solution containing (in mM) 155 NaCl, 3.5 KCl, 1 MgCl2, 1.5 CaCl2, 10 HEPES, 10 glucose, pH adjusted to 7.4 with NaOH for 10-20 min. Then, using a fire-polished Pasteur pipette individual cells were dissociated through gentle trituration. The suspension was added to the recording chamber and the cells were allowed to settle for 10-15 min before the recording chamber was flooded with Tyrode's solution.
Electrophysiological Recordings
Whole-cell patch-clamp recordings were obtained with a Multiclamp 700 B amplifier (Molecular Devices), and Digidata 1322A A/D converter (Molecular Devices), and Clampex 10.3.1.5 software (Molecular Devices) with borosilicate glass electrodes (VWR International) wrapped with Parafilm to reduce pipette capacitance. Pipette resistances were 1.2-2.3 MU when filled with an internal solution containing, (in mM) 122 K-methanesulfonate, 9 NaCl, 9 HEPES, 0.036 CaCl2, 1.62 MgCl 2 , 4 MgATP, 0.3 GTP (Tris salt), 14 creatine phosphate (Tris salt), and 0.18 EGTA, pH 7.4. Series resistance (typically 3-6 MU, no greater than 12 MU) was compensated during voltage-clamp recording by 70% and monitored throughout the experiment. Voltages are corrected for a liquid junction potential of À8 mV between the internal solution and the external solution.
All recordings were made at 37 C. After a gigaohm seal and whole-cell configuration were established, the cell was lifted off the bottom of the recording chamber and placed in front of an array of quartz fiber flow pipes (250 mm internal diameter, 350 mm external diameter) glued onto an aluminum rod whose temperature was controlled by resistive heating elements and a feedback-controlled temperature controller (TC-344B, Warner Instruments). Solutions were changed (in $1 s) by moving the cell from one pipe to another. Dopaminergic neurons were identified by their large size, the presence of slow spontaneous pacemaker firing of wide APs in cellattached or current-clamp recording, and large A-type potassium current (I A ). Tetrodotoxin (1 mM) was added to Tyrode's solution for all voltage-clamp experiments. The effects of exogenous 2-AG developed rapidly (< 1 s) but reversed slowly upon wash-out. However, rapid reversibility could be achieved by adding 1 mg/mL fatty acid-free bovine serum albumin (BSA) to the external Tyrode's solution, as previously described (Boland et al., 2009; Holmqvist et al., 2001; Lishko et al., 2010; Poling et al., 1996; Villarroel and Schwarz, 1996 , also See Figure 7 ). As noted, in some current-clamp recordings, Tyrode's containing 1 mg/mL fat-free BSA was used as the control solution.
Pharmacology
The I A inhibitor AmmTx3 was used at a concentration of 10 nM in order to produce inhibition of $20% (Amendola et al., 2012) in order to match the inhibition produced by 100 nM 2-AG. CB-R antagonists and inverse agonists were used at concentrations known to produce effective receptor inhibition: 1 mM AM251 (Gatley et al., 1997) , 1 mM AM630 (Ross et al., 1999) , 1 nM NESS 0327 (Ruiu et al., 2003) , 10 nM SR 144528 (Rinaldi-Carmona et al., 1998) . The diacylglycerol inhibitor tetrahydrolipstatin was used at 100 nM (Bisogno et al., 2006) and the monoacylglycerol lipase inhibitor JZL184 was used at 30 nM (Long et al., 2009) , preincubating brain slices before dissociation for > 50 min.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data were analyzed using Igor-Pro 6.12A (Wavemetrics) using DataAccess (Bruxton) to read Clampex files. In voltage-clamp experiments, voltage-activated currents were corrected for capacitative currents and linear leak defined by a step from À88 to À93 mV.
Data are presented as representative traces, or in scatterplots where each point is an individual cell, and bar graphs with means ± SEM, where 'n' represents number of cells. When possible (within-group comparisons), significant differences were determined for two group comparisons by Wilcoxon matched-pairs signed rank test, and in more than two group comparisons by nonparametric repeated-measures ANOVA (Friedman test). Significant mean differences in between-group comparisons were determined for two group comparisons by Mann Whitney tests, and in more than two group comparisons by Kruskal-Wallis tests. ANOVAs were followed, when p < 0.05 by Dunn's multiple comparisons post hoc test. A difference of p < 0.05 was considered significant. Exact values are reported unless p < 0.001 or > 0.999. Statistical analysis was performed using GraphPad Prism 6 (GraphPad Software).
